Analysis of osteosarcoma subtypes by clinical genomic testing to identify clinically actionable alterations.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.11019
Abstract: 11019Background: Genomic testing is being utilized with increasing frequency to identify matched therapies for patients (pts) with advanced disease; however, the utility of such testing has not bee... read more here.
Keywords: subtypes clinical; testing identify; clinical genomic; analysis osteosarcoma ... See more keywords
Whole-exome analysis in osteosarcoma to identify a personalized therapy
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.19010
Abstract: Osteosarcoma is the most common pediatric primary non-hematopoietic bone tumor. Survival of these young patients is related to the response to chemotherapy and development of metastases. Despite many advances in cancer research, chemotherapy regimens for… read more here.
Keywords: exome analysis; osteosarcoma; identify personalized; whole exome ... See more keywords